justicedao/ipfs_state_laws huggingface dataset:
855-070-0010 Labeling and Storage of Prophylactics and Contraceptives (1) The use of detachable slip labels or removable ink stamps listing names and addresses of manufacturer, brand name, and expiration date do not meet the labeling requirements of ORS 435.090. (2) As of December 31, 1994, all prophylactics and contraceptives shall bear an expiration date. Prophylactics and contraceptives bearing an expiration date shall not be sold or otherwise distributed beyond that date. (3) Prophylactics and contraceptives shall be stored, displayed, or sold from an area removed from excessive extremes of temperatures which may affect the quality of the products. Statutory/Other Authority: ORS 689.155 & 689.205 History: PB 1-1995, f. & cert. ef. 4-27-95 1PB 1-1984, f. & ef. 2-16-84 1PB 39, f. & ef. 1-8-76 1PB 32, f. 1-31-74, ef. 2-25-74 Reverted to 1PB 18, f. & ef. 10-14-64 1PB 29(Temp), f. & ef. 9-6-73 thru 1-3-74 1PB 18, f. & ef. 10-14-64
855-080-0015 Definitions As used in these rules: (1) "Act" means the Uniform Controlled Substances Act, ORS Chapter 475, and rules thereunder; (2) "CFR" means Code of Federal Regulations; (3) "USC" means United States Code; (4) "Emergency Situations" means those situations in which the prescribing practitioner who authorizes an oral prescription of a controlled substance listed in schedule II of the Federal Controlled Substances Act determines that: (a) Immediate administration of the controlled substance is necessary, for proper treatment of the intended ultimate user; and (b) No appropriate alternative treatment is available, including administration of a drug which is not a controlled substance under schedule II of the Act, and (c) It is not reasonably possible for the prescribing practitioner to provide a written prescription to be presented to the person dispensing the substance prior to the dispensing. (5) Terms not defined in this rule have the definitions set forth in ORS 475.005. Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 475.035, ORS 475.940 & ORS 475.185 History: BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 1-2007, f. & cert. ef. 6-29-07 BP 4-2002, f. 6-27-02, cert. ef. 7-1-02 BP 3-2002(Temp), f. & cert. ef. 3-1-02 thru 8-23-02 PB 5-1991, f. & cert. ef. 9-19-91 1PB 6-1982, f. & ef. 8-6-82 1PB 8-1978, f. & ef. 10-17-78 1PB 6-1978(Temp), f. & ef. 7-1-78
855-080-0020 Schedules Pursuant to ORS 475.005(6) those drugs and their immediate precursors classified in Schedules I through V under the Federal Controlled Substances Act, 21 USC 811 (v. 03/25/2025), 21 USC 812 (v. 03/25/2025) and as amended by the board pursuant to ORS 475.035 are the controlled substances for purposes of regulation and control under the Act. Those schedules are set out in OAR 855-080-0021 through 855-080-0026. [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 475.035 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 8-2010, f. & cert. ef. 6-29-10 PB 5-1991, f. & cert. ef. 9-19-91 PB 4-1987, f. & ef. 3-30-87 1PB 2-1986, f. & ef. 7-10-86 1PB 4-1985, f. & ef. 12-2-85 1PB 2-1985, f. & ef. 7-24-85 1PB 1-1985, f. & ef. 2-27-85 1PB 4-1984(Temp), f. & ef. 9-17-84 1PB 2-1984, f. & ef. 3-7-84 1PB 6-1982, f. & ef. 8-6-82 1PB 8-1978, f. & ef. 10-17-78 1PB 6-1978(Temp), f. & ef. 7-1-78
855-080-0022 Schedule II Schedule II consists of the drugs and other substances by whatever official, common, usual, chemical, or brand name designated, listed in 21 CFR 1308.12 (v. 04/01/2024) and any quantity of methamphetamine, when in the form of a FDA approved product containing methamphetamine, its salts, isomers, and salts of its isomers as an active ingredient for the purposes of currently accepted medical use. [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 475.005, ORS 475.035, ORS 475.055 & ORS 475.065 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 10-2017, amend filed 12/22/2017, effective 12/26/2017 BP 10-2014, f. 12-30-14, cert. ef. 1-1-15 BP 8-2010, f. & cert. ef. 6-29-10 BP 1-2007, f. & cert. ef. 6-29-07 BP 4-2006, f. 6-9-06, cert. ef. 7-1-06 BP 4-2000, f. & cert. ef. 2-16-00 Reverted to PB 1-1997, f. & cert. ef. 9-22-97 BP 3-1999(Temp), f. & cert. ef. 8-9-99 thru 1-17-00 PB 1-1997, f. & cert. ef. 9-22-97 PB 1-1996, f. & cert. ef. 4-5-96 PB 1-1994, f. & cert. ef. 2-2-94 PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92) PB 5-1991, f. & cert. ef. 9-19-91 PB 9-1990, f. & cert. ef. 12-5-90 PB 15-1989, f. & cert. ef. 12-26-89 PB 10-1987, f. & ef. 12-8-87 PB 8-1987, f. & ef. 9-30-87 PB 4-1987, f. & ef. 3-30-87
855-080-0023 Schedule III Schedule III consists of the drugs and other substances by whatever official, common, usual, chemical, or brand name designated, listed in 21 CFR 1308.13 (v. 04/01/2024). [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.205 & ORS 475.973 Statutes/Other Implemented: ORS 475.035 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 42-2021, amend filed 12/16/2021, effective 01/01/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 1-2007, f. & cert. ef. 6-29-07 BP 4-2006, f. 6-9-06, cert. ef. 7-1-06 BP 9-2000, f. & cert. ef. 6-29-00 BP 4-2000, f. & cert. ef. 2-16-00 Reverted to PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92) BP 3-1999(Temp), f. & cert. ef. 8-9-99 thru 1-17-00 PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92) PB 5-1991, f. & cert. ef. 9-19-91 PB 11-1989, f. & cert. ef. 7-20-89 PB 4-1987, f. & ef. 3-30-87
855-080-0024 Schedule IV Schedule IV consists of the drugs and other substances, by whatever official, common, usual, chemical, or brand name designated, listed in 21 CFR 1308.14 (v. 04/01/2024), unless specifically excepted or listed in another schedule. [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 475.035 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 1-2007, f. & cert. ef. 6-29-07 BP 9-2000, f. & cert. ef. 6-29-00 BP 4-2000, f. & cert. ef. 2-16-00 PB 1-1997, f. & cert. ef. 9-22-97 PB 1-1996, f. & cert. ef. 4-5-96 PB 1-1995, f. & cert. ef. 4-27-95 PB 1-1992, f. & cert. ef. 1-31-92 (and corrected 2-7-92) PB 5-1991, f. & cert. ef. 9-19-91 PB 4-1987, f. & ef. 3-30-87
855-080-0028 Excluded or Exempted Substances (1) The board adopts the excluded substances list found in 21 CFR 1308.22 (v. 04/01/2024). (2) The board adopts the exempt chemical preparations list found in 21 CFR 1308.24 (v. 04/01/2024). (3) The board adopts the exempted prescription products list in the Table of Exempted Prescription Products (v. 02/11/2025) pursuant to 21 CFR 1308.32 (v. 04/01/2024). [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.205 & ORS 475.035 Statutes/Other Implemented: ORS 689.155 & ORS 475.035 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 42-2021, amend filed 12/16/2021, effective 01/01/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 8-2010, f. & cert. ef. 6-29-10 BP 8-2006, f. & cert. ef. 12-19-06 BP 6-2006(Temp), f. & cert. ef. 8-25-06 thru 1-31-07 BP 4-2006, f. 6-9-06, cert. ef. 7-1-06 PB 1-1995, f. & cert. ef. 4-27-95 PB 5-1991, f. & cert. ef. 9-19-91 PB 4-1987, f. & ef. 3-30-87, Renumbered from 855-080-0025 1PB 6-1982, f. & ef. 8-6-82 1PB 8-1978, f. & ef. 10-17-78 1PB 6-1978(Temp), f. & ef. 7-1-78
855-080-0029 Acceptable Subpoenas for Law Enforcement Agencies to Obtain Pseudoephedrine or Ephedrine Log Information (1) “Law Enforcement Agency” includes the following: (a) County sheriffs, municipal police departments, police departments established by a university under ORS 352.121 or 353.125 and state police; (b) Other police officers of this state or another state, including humane special agents as defined in ORS 181A.345; (c) The Oregon Department of Justice when conducting a criminal investigation; (d) A tribal government as defined in ORS 181A.680 that employs authorized tribal police officers as defined in ORS 181A.680; and (e) Law enforcement agencies of the federal government. (2) Acceptable subpoenas for a law enforcement agency to obtain information in a pseudoephedrine or ephedrine log are subpoenas lawfully issued by: (a) A grand jury under ORS 136.563; (b) A district attorney under ORS 136.565; (c) The Oregon Attorney General under ORS 183.073; (d) A law enforcement agency of a tribal government under tribal subpoena authority; and (e) A federal law enforcement agency under federal subpoena power. (3) Subpoenas that meet the criteria in (2) are accepted by the Board under section 2, subsection 5 of HB 2648 (2021). The Board does not act as a decisionmaker as to a subpoena issued for pseudoephedrine or ephedrine logs under this rule. The Board is not a party to a subpoena for information contained in a pseudoephedrine or ephedrine log under this rule. Statutory/Other Authority: ORS 689.205 & 2021 HB 2648 Statutes/Other Implemented: 2021 HB 2648 & ORS 475.035 History: BP 42-2021, adopt filed 12/16/2021, effective 01/01/2022
855-080-0031 Registration Requirements (1) Every person who manufactures, delivers, or dispenses any controlled substance within this state or who proposes to engage in the manufacture, delivery or dispensing of any controlled substance within this state must obtain a controlled substance registration annually issued by the State Board of Pharmacy. (2) The board adopts the exceptions to registration for distribution by dispenser to another practitioner pursuant to 21 CFR 1307.11 (v. 04/01/2024). (3) The board adopts the exceptions to registration for the incidental manufacture of controlled substances pursuant to 21 CFR 1307.13 (v. 04/01/2024). [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.155 & ORS 689.205 Statutes/Other Implemented: ORS 475.125 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 42-2021, amend filed 12/16/2021, effective 01/01/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 1-2007, f. & cert. ef. 6-29-07 BP 4-2006, f. 6-9-06, cert. ef. 7-1-06 1PB 6-1982, f. & ef. 8-6-82
855-080-0041 Exemption to Registration The following persons are not required to register to manufacture, dispense or deliver controlled substances and may lawfully possess controlled substances under ORS 475.005 to ORS 475.285 and ORS 475.752 to ORS 475.980: (1) An agent or employee of any registered manufacturer, distributor or dispenser of any controlled substance if the agent or employee is acting in the usual course of business or employment. (2) A common or contract carrier or warehouseman, or an employee thereof, whose possession of any controlled substance is in the usual course of business or employment. (3) An ultimate user or a person in possession of any controlled substance pursuant to a lawful order of a practitioner or in lawful possession of a Schedule V substance, unless otherwise prohibited. (4) A practitioner otherwise licensed under the laws of this state and authorized to dispense or administer a controlled substance by the licensing authority. (5) A person providing proof of a valid DEA registration certificate pursuant to ORS 475.135(3) conducting research with controlled substances in Sections I through V within this state. Statutory/Other Authority: ORS 689.155 & ORS 689.205 Statutes/Other Implemented: ORS 475.125 & ORS 475.135 History: BP 20-2021, adopt filed 06/15/2021, effective 06/15/2021
855-080-0065 Security (1) All applicants and registrants as applicable to the registration classification must comply with the security requirements of 21 CFR 1301.01 (v. 04/01/2024), 21 CFR 1301.02 (v. 04/01/2024), 21 CFR 1301.71 (v. 04/01/2024), 21 CFR 1301.72 (v. 04/01/2024), 21 CFR 1301.73 (v. 04/01/2024), 21 CFR 1301.74 (v. 04/01/2024), 21 CFR 1301.75 (v. 04/01/2024), 21 CFR 1301.76 (v. 04/01/2024), 21 CFR 1301.77 (v. 04/01/2024), 21 CFR 1301.90 (v. 04/01/2024), 21 CFR 1301.91 (v. 04/01/2024), 21 CFR 1301.92 (v. 04/01/2024), and 21 CFR 1301.93 (v. 04/01/2024). (2) The security requirements of (1) of this rule apply to all controlled substances, as defined in these rules, including ephedrine, pseudoephedrine, and phenylpropanolamine. (3) Applicants and registrants must guard against theft and diversion of ephedrine, pseudoephedrine, and phenylpropanolamine. [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 475.135 & ORS 475.125 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 1-2007, f. & cert. ef. 6-29-07 BP 4-2006, f. 6-9-06, cert. ef. 7-1-06 PB 5-1991, f. & cert. ef. 9-19-91 1PB 6-1982, f. & ef. 8-6-82 1PB 8-1978, f. & ef. 10-17-78 1PB 6-1978(Temp), f. & ef. 7-1-78
855-080-0070 Records and Inventory (1) All registrants must, as applicable to the registration classification, keep records and maintain inventories in compliance with 21 USC 827 (v. 03/25/2025); 21 CFR 1304.01 (v. 04/01/2024), 21 CFR 1304.02 (v. 04/01/2024), 21 CFR 1304.03 (v. 04/01/2024), 21 CFR 1304.04 (v. 04/01/2024), 21 CFR 1304.05 (v. 04/01/2024), 21 CFR 1304.06 (v. 04/01/2024); 21 CFR 1304.11 (v. 04/01/2024); 21 CFR 1304.21 (v. 04/01/2024), 21 CFR 1304.22 (v. 04/01/2024), 21 CFR 1304.23 (v. 04/01/2024), 21 CFR 1304.24 (v. 04/01/2024), 21 CFR 1304.25 (v. 04/01/2024), 21 CFR 1304.26 (v. 04/01/2024); 21 CFR 1304.31 (v. 04/01/2024), 21 CFR 1304.32 (v. 04/01/2024), 21 CFR 1304.33 (v. 04/01/2024). (2) A written inventory of all controlled substances must be taken by registrants annually within 367 days of the last written inventory. (3) All such records must be maintained for a period of three years. [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 475.035 & ORS 689.205 Statutes/Other Implemented: ORS 475.165 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 1-2007, f. & cert. ef. 6-29-07 BP 4-2006, f. 6-9-06, cert. ef. 7-1-06 PB 1-1994, f. & cert. ef. 2-2-94 PB 5-1991, f. & cert. ef. 9-19-91 PB 10-1987, f. & ef. 12-8-87 1PB 1-1986, f. & ef. 6-5-86 1PB 6-1982, f. & ef. 8-6-82 1PB 8-1978, f. & ef. 10-17-78 1PB 6-1978(Temp), f. & ef. 7-1-78
855-080-0075 Orders for Schedule I and II Controlled Substances Controlled substances in Schedules I and II must be distributed by a registrant to another registrant only pursuant to an order form or electronic order in compliance with 21 USC 828 (v. 04/01/2024) and 21 CFR 1305.01 (v. 04/01/2024), 21 CFR 1305.02 (v. 04/01/2024), 21 CFR 1305.03 (v. 04/01/2024), 21 CFR 1305.04 (v. 04/01/2024), 21 CFR 1305.05 (v. 04/01/2024), 21 CFR 1305.06 (v. 04/01/2024), 21 CFR 1305.07 (v. 04/01/2024); 21 CFR 1305.11 (v. 04/01/2024), 21 CFR 1305.12 (v. 04/01/2024), 21 CFR 1305.13 (v. 04/01/2024), 21 CFR 1305.14 (v. 04/01/2024), 21 CFR 1305.15 (v. 04/01/2024), 21 CFR 1305.16 (v. 04/01/2024), 21 CFR 1305.17 (v. 04/01/2024), 21 CFR 1305.18 (v. 04/01/2024), 21 CFR 1305.19 (v. 04/01/2024), 21 CFR 1305.20 (v. 04/01/2024); 21 CFR 1305.21 (v. 04/01/2024), 21 CFR 1305.22 (v. 04/01/2024), 21 CFR 1305.23 (v. 04/01/2024), 21 CFR 1305.24 (v. 04/01/2024), 21 CFR 1305.25 (v. 04/01/2024), 21 CFR 1305.26 (v. 04/01/2024), 21 CFR 1305.27 (v. 04/01/2024), 21 CFR 1305.28 (v. 04/01/2024), and 21 CFR 1305.29 (v. 04/01/2024). [Publications: Publications referenced are available for review at the agency.] Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 475.175 History: BP 3-2025, amend filed 06/16/2025, effective 06/16/2025 BP 57-2024, amend filed 06/18/2024, effective 06/20/2024 BP 10-2023, amend filed 06/13/2023, effective 06/13/2023 BP 27-2022, amend filed 06/15/2022, effective 06/16/2022 BP 20-2021, amend filed 06/15/2021, effective 06/15/2021 BP 4-2006, f. 6-9-06, cert. ef. 7-1-06 PB 5-1991, f. & cert. ef. 9-19-91 1PB 8-1978, f. & ef. 10-17-78 1PB 6-1978(Temp), f. & ef. 7-1-78
855-102-0010 Board Meetings (1) Board meetings must be held not less than once every three months as designated by the board. (2) The President of the board has the power to call special meetings, subject to ORS 689.185, when it may be deemed necessary or upon request of a majority of members. (3) The board must hold an annual meeting each year for the election of officers, the reorganization of the board and the transaction of other business. Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 689.135 & ORS 689.185 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0015 Public Health and Pharmacy Formulary Advisory Committee (PHPFAC) Meetings (1) A PHPFAC meeting must be held not less than once every six months. (2) The PHPFAC must periodically review the formulary and protocol compendium and recommend the revisions to the board for adoption by rule. (3) The PHPFAC must recommend to the board, for adoption by rule, a formulary of drugs and devices from which a Pharmacist can prescribe and dispense to a patient pursuant to a diagnosis by a qualified healthcare practitioner or a protocol from which a Pharmacist can prescribe and dispense. Statutory/Other Authority: ORS 689.649 Statutes/Other Implemented: ORS 689.645 & ORS 689.649 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0020 Board and PHPFAC Member Compliance Board members and PHPFAC members must comply with the requirements of all Oregon public records and public meeting laws. Statutory/Other Authority: ORS 192.001 & ORS 192.620 Statutes/Other Implemented: ORS 192.630 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0030 Board and PHPFAC Member Compensation (1) A board member and Public Health and Pharmacy Formulary Advisory Committee (PHPFAC) member of the Oregon Board of Pharmacy who is entitled to compensation under ORS 292.495 is eligible to receive an amount equal to the per diem amount paid to members of the Legislative Assembly under ORS 171.072 when engaged in the performance of official duties for each day or portion thereof. (2) For the purpose of compensation, a board member or PHPFAC member is considered engaged in the performance of official duties when: (a) The activity furthers the board’s mission, such as attending a board meeting; (b) Engaged in an activity at the request of the board chair or authorized by a vote of the board in advance of the activity; or (c) Attending an authorized meeting. (3) Except as otherwise provided by law, all members, including those employed in full-time public service, may receive actual and necessary travel or other expenses actually incurred in the performance of their official duties within the limits provided by law or by the Oregon Department of Administrative services under ORS 292.210, ORS 292.220, ORS 292.230, and ORS 292.250. (4) A board member or PHPFAC member is not required to accept compensation or reimbursement of travel expenses while performing their official duties as a board or appointed committee member. Statutory/Other Authority: ORS 689.115 & ORS 689.205 Statutes/Other Implemented: ORS 171.072, ORS 292.495, ORS 689.115, ORS 689.175, ORS 689.645 & ORS 689.649 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0040 Adoption by Reference - General (1) The board adopts standards and other publications by reference, as necessary, through administrative rule. When a matter is included in a referenced publication that is in conflict with Oregon Revised Statutes or Oregon Administrative Rules, the statute or rule applies and the standard provision does not. All remaining parts or application of the standard remain in effect. (2) All outside standards, statutes, rules and publications referred to in any rules adopted by the board are by those references made a part of those rules as though fully set forth. Copies are available for inspection in the office of the Board of Pharmacy. Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 689.205 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0045 Adoption by Reference - Model Rules of Procedure Pursuant to the provisions of ORS 183.341, the Board of Pharmacy adopts the Attorney General’s Uniform and Model Rules of Procedure under the Administrative Procedures Act effective 07/2019. These rules must be controlling except as otherwise required by statute or rule. [ED. NOTE: The full text of the Attorney General’s Model Rules of Procedure is available from the office of the Attorney General or Board of Pharmacy.] Statutory/Other Authority: ORS 183.341 Statutes/Other Implemented: ORS 183.341 & ORS 689.205 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0050 Coaching from Board Members and Staff A board member or board staff must not: (1) Discuss the contents of an examination, its preparation or use with any candidate or other person; (2) Coach a candidate or any other person on materials that may be used in the examination; or (3) Accept any fees for any act of assistance that would bear on the examination. Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 689.195 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0055 Board Compliance Director and Officers The board’s Compliance Director and Compliance Officers: (1) Must be Pharmacists licensed in the State of Oregon; and (2) Are authorized to provide appropriate deadline extensions. Statutory/Other Authority: ORS 689.205 Statutes/Other Implemented: ORS 689.195 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024
855-102-0060 License Verification For purposes of license verification, a person may rely upon the licensing information as it is displayed on the board's website that includes the issuance and expiration dates of any license issued by the board. Statutory/Other Authority: ORS 689.151 & ORS 689.490 Statutes/Other Implemented: ORS 689.151, ORS 689.205 & ORS 689.490 History: BP 14-2023, adopt filed 08/15/2023, effective 03/01/2024